Toward a vision for the development, study, and use of electronic health technology for and by people with psychiatric and/or substance use disorders: A strengths, weaknesses, opportunities, and threats analysis and illustration

Abraham Rudnick, David Roe

Research output: Contribution to journalComment/Debate

Original languageEnglish
Pages (from-to)333-336
Number of pages4
JournalJournal of Dual Diagnosis
Volume8
Issue number4
DOIs
StatePublished - 1 Nov 2012

Bibliographical note

Funding Information:
Dr. Rudnick has received research and development related financial support from Astra Zeneca, Eli Lilly, Janssen-Ortho, Mylan, and Novartis, manufacturers of psychotropic medications, in order to advance mental health care. He has also co-received research and development related financial support from Telus and Microsoft, communication and electronic industry companies, in order to advance mental healthcare. Dr. Roe identifies no involvement with private or related industry.

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this